Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103497145B details a scalable chiral resolution process for donepezil intermediates, offering high purity and cost-effective supply chain solutions for pharmaceutical manufacturing.
Novel synthesis route for tetrahydroprotoberberine compounds via Bischler-Napieralski reaction. Enables batch production of l-SPD and d-SPD with high optical purity.
Patent CN101891647A details a novel Ubenimex preparation using L-lysine resolution and EDCI/HOAt coupling, ensuring >99.5% purity and robust supply chain reliability.
Patent CN108047125A details a low-cost synthesis route for Argatroban intermediates. Achieve high purity and scalable supply chain reliability with optimized manufacturing processes.
Novel three-step process for Ritlecitinib Tosylate reduces chromatography steps. Ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN109134351B details a novel synthesis of S-3-(4-aminophenyl)piperidine with >99% ee, offering cost-effective scalability for PARP inhibitor manufacturing.
Patent CN114315609A discloses a novel 3-step process for cis-2-aminocyclohexanol from cyclohexene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN101591250A details a streamlined one-step Mannich synthesis and tartaric acid resolution for high-purity chiral amino alcohol ligands, offering significant cost and supply chain advantages.
Novel synthesis of Remdesivir intermediates via CN113214320A offers high purity and scalable manufacturing. Discover cost-effective supply chain solutions for antiviral API production.
Patent CN110885315A details a high-yield synthesis of (R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one using early-stage resolution for superior purity and cost efficiency.
Patent CN108409615B reveals a scalable method for enantiopure tert-butyl sulfinamide. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with this novel route.
Patent CN112939841B enables low-cost synthesis of chiral amino acid intermediates without palladium catalysts, ensuring scalable supply chain reliability.
Patent CN119060059B details a novel three-step synthesis for Ritlecitinib Tosylate offering enhanced purity and scalable manufacturing efficiency for global pharmaceutical supply chains.
Patent CN112430235B details a cost-effective synthesis of PF-06651600 intermediate using mild hydrogenation and chiral resolution for scalable pharmaceutical manufacturing.
Novel 5-step synthesis reduces corrosion and waste. Ideal for high-purity pharmaceutical intermediate supply chains seeking cost efficiency.
Patent CN114409552B reveals a high-purity levosalbutamol hydrochloride method. This report analyzes cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Patent CN111056939A reveals a novel recrystallization method for (1R,3S)-3-aminocyclopentanol, offering high optical purity and yield for Bictegravir synthesis.
Patent CN120737008B details a novel chiral resolution method eliminating chromatographic columns. Mild nitration ensures high purity. Scalable synthesis reduces manufacturing costs for global supply chains.
Patent CN101743218B reveals a superior resolution method for trans-2-aminocyclohexanol using 2-methoxyphenylacetic acid, offering high yield and cost-effective manufacturing for pharmaceutical intermediates.